Related Experiment Video
Updated: Jul 2, 2026
07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Efficient cross-presentation depends on autophagy in tumor cells
Yuhuan Li1, Li-Xin Wang, Guojun Yang
1Laboratory of Cancer Immunobiology, Providence Portland Medical Center, OR 97213-2967, USA.
Cancer Research
|September 2, 2008
Summary
Autophagy in tumor cells is essential for cross-presentation by dendritic cells. Enhancing autophagy boosts tumor antigen cross-presentation, suggesting autophagosomes as potential cancer vaccines.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Cross-presentation of antigens by dendritic cells is crucial for adaptive immunity against tumors and pathogens.
- The regulatory role of autophagy in tumor antigen cross-presentation remains largely unknown.
Purpose of the Study:
- To investigate the role of macroautophagy in tumor cells in the process of antigen cross-presentation.
- To explore the potential of autophagosomes as vaccine candidates for cancer immunotherapy.
Main Methods:
- Utilized HEK 293T cells expressing ovalbumin (OVA) and melanoma cells as antigen donors.
- Assessed cross-presentation by dendritic cells both in vitro and in vivo.
- Manipulated macroautophagy levels (inhibition and induction) in tumor cells.
- Isolated and analyzed autophagosomes for antigen-carrying capacity.
Main Results:
- Macroautophagy in tumor cells was found to be essential for dendritic cell-mediated cross-presentation.
- Inhibition of autophagy led to a near-complete abolishment of cross-presentation.
- Induction of autophagy significantly enhanced the cross-presentation of tumor antigens.
- Purified autophagosomes demonstrated efficacy as antigen carriers for cross-presentation.
Conclusions:
- Autophagy plays a novel, active role in sequestering and delivering tumor antigens for cross-presentation.
- Isolated autophagosomes show promise as potent vaccines for immunotherapy against cancer and infectious diseases.
Related Concept Videos
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...